What is a “Modified Nucleotide” according to MPEP 2412.03(e)?
According to MPEP 2412.03(e), a “Modified nucleotide” is defined as follows:
“Modified nucleotide” includes any nucleotide as described in paragraph 3(f) of WIPO Standard ST.26.
Further explanation from WIPO Standard ST.26 states that a modified nucleotide is any nucleotide other than the standard DNA and RNA nucleotides. Specifically, it excludes:
- deoxyadenosine 3′-monophosphate
- deoxyguanosine 3′-monophosphate
- deoxycytidine 3′-monophosphate
- deoxythymidine 3′-monophosphate
- adenosine 3′-monophosphate
- guanosine 3′-monophosphate
- cytidine 3′-monophosphate
- uridine 3′-monophosphate
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2412.03(E) - "Modified Nucleotide",
Patent Law,
Patent Procedure